These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23615769)

  • 41. Initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction is related to platelet response to aspirin.
    Skoric B; Milicic D; Lovric D; Gornik I; Skoric KN; Sertic J
    Int J Cardiol; 2010 Apr; 140(3):356-8. PubMed ID: 19046612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
    Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W
    Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. P2Y12 platelet reactivity after thrombolytic therapy for ST-segment elevation myocardial infarction.
    Diego A; de Prado AP; Cuellas C; de Miguel A; Samaniego B; Alonso-Rodríguez D; Bangueses R; Vega B; Martín J; Fernandez-Vazquez F
    Thromb Res; 2012 Sep; 130(3):e31-6. PubMed ID: 22704077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High on-clopidogrel treatment platelet reactivity in Thai patients with chronic stable angina scheduled for percutaneous coronary intervention.
    Phankingthongkum R; Panchavinnin P; Chinthammitr Y; Tresukosol D; Chotinaiwattarakul C; Tungsubutra W; Wongpraparut N; Kitrattana B; Leewanun P
    J Med Assoc Thai; 2013 May; 96(5):538-43. PubMed ID: 23745307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).
    Patti G; Mangiacapra F; Ricottini E; Cannatà A; Cavallari I; Vizzi V; D'Ambrosio A; Dicuonzo G; Di Sciascio G
    Am J Cardiol; 2013 Jun; 111(12):1739-44. PubMed ID: 23538022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A high loading dose of clopidogrel reduces myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging study.
    Song YB; Hahn JY; Gwon HC; Chang SA; Lee SC; Choe YH; Choi SH; Choi JH; Lee SH; Oh JK
    Am Heart J; 2012 Mar; 163(3):500-7. PubMed ID: 22424023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry.
    Choi CU; Rha SW; Oh DJ; Poddar KL; Na JO; Kim JW; Lim HE; Kim EJ; Park CG; Seo HS; Hong TJ; Park JS; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim HS; Kim CJ; Yoon JH; Ahn TH; Tahk SJ; Chung WS; Seung KB; Chae SC; Park SJ; Ahn YK; Jeong MH
    Am Heart J; 2011 Feb; 161(2):373-382.e1-3. PubMed ID: 21315222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of high on-treatment platelet reactivity early after clopidogrel loading in ST-elevation myocardial infarction.
    Alexopoulos D; Xanthopoulou I; Tsigkas G; Damelou A; Theodoropoulos KC; Kassimis G; Chouchoulis K; Davlouros P; Chiladakis J; Hahalis G
    Circ J; 2012; 76(9):2183-7. PubMed ID: 22664584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.
    Lepäntalo A; Virtanen KS; Heikkilä J; Wartiovaara U; Lassila R
    Eur Heart J; 2004 Mar; 25(6):476-83. PubMed ID: 15039127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomes.
    Cuisset T; Quilici J; Loosveld M; Gaborit B; Grosdidier C; Fourcade L; Gil JM; Moro PJ; Morange PE; Bonnet JL; Alessi MC
    Am Heart J; 2012 Sep; 164(3):327-33. PubMed ID: 22980298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy.
    Bobbert P; Stellbaum C; Steffens D; Schütte C; Bobbert T; Schultheiss HP; Rauch U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):723-8. PubMed ID: 23135379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
    Di Sciascio G; Patti G; Pasceri V; Gatto L; Colonna G; Montinaro A;
    J Am Coll Cardiol; 2010 Aug; 56(7):550-7. PubMed ID: 20688209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High on treatment platelet reactivity and stent thrombosis.
    Rajendran S; Parikh D; Shugman I; French JK; Juergens CP
    Heart Lung Circ; 2011 Aug; 20(8):525-31. PubMed ID: 21592858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tirofiban use with clopidogrel and aspirin decreases adverse cardiovascular events after percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.
    Sethi A; Bahekar A; Doshi H; Bhuriya R; Bedi U; Singh S; Khosla S
    Can J Cardiol; 2011; 27(5):548-54. PubMed ID: 21871775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
    Chen WH; Lee PY; Ng W; Tse HF; Lau CP
    J Am Coll Cardiol; 2004 Mar; 43(6):1122-6. PubMed ID: 15028378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
    Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
    Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Chen F; Kent KM; Satler LF; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2013 Mar; 111(6):841-5. PubMed ID: 23273719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Influence of the double antiplatelet therapy on patency of the occluded artery after acute myocardial infarction with ST-segment elevation].
    Radojković DD; Perisić Z; Tomasević M; Pavlović M; Apostolović S; Janković R; Damjanović M; Martinović SS; Bozinović N; Milenković D
    Vojnosanit Pregl; 2007 Feb; 64(2):117-21. PubMed ID: 17348463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.